Type II diabetes: Synjardy® approved in the EU

Synjardy® has been granted marketing authorisation by the European Commission for the treatment of adults with type II diabetes (T2D) in the European Union (EU). Synjardy® is a new single-pill combination therapy from the Boehringer Ingelheim and Eli Lilly and Company diabetes alliance.
Source: Pharmacy Europe - Category: Drugs & Pharmacology Authors: Tags: *** Editor's Pick Clinical trials Practical therapeutics Diabetes blood glucose-lowering drugs empagliflozin glycaemic control Jardiance Latest News metformin odium glucose cotransporter 2 SGLT2 synjardy T2D Source Type: news